Fig. 3: Timeline of BA.1.23 evolution compared to antibody levels and treatments.
From: Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants
a The timeline of BA.1.23 infected patients’ positive (red croses) or negative (open blue circles) nucleic acid amplification test (NAAT) for SARS-CoV-2 (top). The N gene target cycle threshold (Ct) values for respiratory specimens, for different diagnostic methods is shown (bottom panel). The NAAT panel only includes data points from positive tests that reported a Ct value. b Number of nucleotide substitutions in the consensus sequence relative to Omicron BA.1 in the sequenced specimens. c SARS-CoV-2 spike-binding IgG antibody levels for P1–P4. Antibody levels are shown in arbitrary units per mL (Arb. units/mL). Documented vaccine administrations are indicated. d Timeline of SARS-CoV-2 antiviral treatments received by P1–P4. Treatment duration is indicated by the length of the bar. Source data provided in the Source Data file.
